thalidomide has been researched along with ascorbic acid in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (30.00) | 18.7374 |
| 1990's | 2 (20.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (40.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Bharate, SB; Mudududdla, R; Nuthakki, VK | 1 |
| Boisnic, S; Tovaru, S | 1 |
| Köhler, E; Neubert, D | 1 |
| Brode, E | 1 |
| Ignat'eva, TV; Popov, VB; Vaĭsman, BL | 1 |
| Vaisman, B | 1 |
| Advani, A; Bejanyan, N; Chan, J; Jankowska, A; Kalaycio, M; Maciejewski, JP; Mooney, L; Raza, A; Saunthararajah, Y; Sekeres, MA; Tiu, RV | 1 |
| Aikawa, N; Kunisato, A; Kusaka, H; Nagao, K; Ohgami, K; Takaba, K | 1 |
4 review(s) available for thalidomide and ascorbic acid
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Role of basic aminoalkyl chains in the lead optimization of Indoloquinoline alkaloids.
Topics: Alkaloids; Antimalarials; Antineoplastic Agents; Cell Proliferation; Indoles; Malaria; Molecular Structure; Neoplasms; Quinolines | 2022 |
[Evaluation and treatment of aphthous ulcerations of the mouth].
Topics: Anti-Infective Agents, Local; Ascorbic Acid; Behcet Syndrome; Colchicine; Diagnosis, Differential; Humans; Inosine Pranobex; Mouthwashes; Prednisone; Stomatitis, Aphthous; Stomatitis, Herpetic; Thalidomide | 1991 |
Mechanism of teratogenic action of thalidomide.
Topics: Abnormalities, Drug-Induced; Animals; Ascorbic Acid; Extremities; Female; Humans; Immune System Diseases; Infant, Newborn; Pregnancy; Species Specificity; Teratogens; Thalidomide | 1996 |
1 trial(s) available for thalidomide and ascorbic acid
| Article | Year |
|---|---|
A phase 2 trial of combination therapy with thalidomide, arsenic trioxide, dexamethasone, and ascorbic acid (TADA) in patients with overlap myelodysplastic/myeloproliferative neoplasms (MDS/MPN) or primary myelofibrosis (PMF).
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Ascorbic Acid; Dexamethasone; Disease-Free Survival; Female; Humans; Male; Myelodysplastic-Myeloproliferative Diseases; Oxides; Primary Myelofibrosis; Thalidomide | 2012 |
5 other study(ies) available for thalidomide and ascorbic acid
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Hypothetical explanation of the embryotoxic action of thalidomide.
Topics: Animals; Ascorbic Acid; Collagen; Embryo, Mammalian; Embryo, Nonmammalian; Female; Isoenzymes; Ketoglutaric Acids; Mixed Function Oxygenases; Pregnancy; Proline; Thalidomide | 1970 |
[Experimental studies with cyclic imides. I. Modification of hypophyseal-adrenal axis by thalidomide].
Topics: 17-Ketosteroids; Adrenal Cortex Hormones; Adrenal Glands; Adrenocorticotropic Hormone; Animals; Ascorbic Acid; Corticosterone; Depression, Chemical; Female; Guinea Pigs; Ovary; Pituitary Gland; Pituitary-Adrenal System; Rats; Stimulation, Chemical; Thalidomide; Time Factors | 1968 |
[Decrease in the ascorbic acid content of guinea pig tissues caused by thalidomide].
Topics: Adrenal Glands; Aniline Hydroxylase; Animals; Ascorbic Acid; Depression, Chemical; Female; Guinea Pigs; Kidney; Liver; Microsomes, Liver; Phenobarbital; Rabbits; Spleen; Swine; Teratogens; Thalidomide | 1983 |
Detection of thalidomide embryotoxicity by in vitro embryotoxicity testing based on human iPS cells.
Topics: Ascorbic Acid; Cell Differentiation; Cells, Cultured; Embryonic Stem Cells; Fibroblasts; Humans; Induced Pluripotent Stem Cells; Myocytes, Cardiac; Skin; Teratogens; Thalidomide; Toxicity Tests; Valproic Acid | 2014 |